12.04.14
Irvine, Calif.-based MRI Interventions Inc. has added medical device beteran Wendelin Maners as vice president of marketing as new CEO Frank Grillo builds his management team. Maners will head all marketing activities and programs, as well as develop and lead internal and external training programs for the company.
Maners joins MRI Interventions with more than two decades of global medical device experience focused on the marketing, acquisition, and licensing of medical device technologies. Prior to joining MRI Interventions, Maners served as vice president, emerging technologies with CSA Medical, where she managed commercial marketing for the company’s products, led market development efforts for the company’s emerging applications in new market and disease segments and developed internal and external product training programs. Prior to her time with CSA Medical, she served for over 14 years in various roles at Boston Scientific Corporation, most recently as vice president, strategy and business development. During that time, she developed and executed acquisition strategies in the Neuromodulation and Electrophysiology markets, managed and built technology and venture capital business relationships to assemble a portfolio of investment options for supported divisions and served as a delegate board member/observer for Boston Scientific investments, including Cyberonics, Northstar Neuroscience, Neuropace, Intelect Medical, IntraPace, Quallion and MRI Interventions. Maners is a graduate of the University of Southern California’s Marshall School of Business.
“I am excited to join the MRI Interventions team and eager to build on the work that has already been done to drive the growth of the ClearPoint system as a platform for a variety of existing and new minimally invasive neurosurgical procedures,” Maners said. “ClearPoint is a unique and disruptive technology that marks a new era of real-time visualization for minimally invasive neurosurgery. I am delighted to be a part of the commercialization of a product that I believe is helping neurosurgeons offer better care to their patients.”
“Wendelin possesses the skills and background we need to solidify our ClearPoint marketing strategy as we strive to best capitalize on the large and growing opportunity in the neuro market,” said Frank Grillo. “She is familiar with the challenges inherent in marketing emerging medical technologies and will be a valuable asset in our commercialization of our ClearPoint platform. I am very pleased to have her on the MRI Interventions team.”
Grillo joined MRI Interventions as President on Oct. 6 and will become CEO on Jan. 1. Former COE Kimble Jenkins, who has led the company since 2003, will assume the position of executive chairman on Jan. 1 and will continue to be actively involved with the company.
MRI Interventions makes platforms for minimally invasive surgical procedures in the brain and heart.
Maners joins MRI Interventions with more than two decades of global medical device experience focused on the marketing, acquisition, and licensing of medical device technologies. Prior to joining MRI Interventions, Maners served as vice president, emerging technologies with CSA Medical, where she managed commercial marketing for the company’s products, led market development efforts for the company’s emerging applications in new market and disease segments and developed internal and external product training programs. Prior to her time with CSA Medical, she served for over 14 years in various roles at Boston Scientific Corporation, most recently as vice president, strategy and business development. During that time, she developed and executed acquisition strategies in the Neuromodulation and Electrophysiology markets, managed and built technology and venture capital business relationships to assemble a portfolio of investment options for supported divisions and served as a delegate board member/observer for Boston Scientific investments, including Cyberonics, Northstar Neuroscience, Neuropace, Intelect Medical, IntraPace, Quallion and MRI Interventions. Maners is a graduate of the University of Southern California’s Marshall School of Business.
“I am excited to join the MRI Interventions team and eager to build on the work that has already been done to drive the growth of the ClearPoint system as a platform for a variety of existing and new minimally invasive neurosurgical procedures,” Maners said. “ClearPoint is a unique and disruptive technology that marks a new era of real-time visualization for minimally invasive neurosurgery. I am delighted to be a part of the commercialization of a product that I believe is helping neurosurgeons offer better care to their patients.”
“Wendelin possesses the skills and background we need to solidify our ClearPoint marketing strategy as we strive to best capitalize on the large and growing opportunity in the neuro market,” said Frank Grillo. “She is familiar with the challenges inherent in marketing emerging medical technologies and will be a valuable asset in our commercialization of our ClearPoint platform. I am very pleased to have her on the MRI Interventions team.”
Grillo joined MRI Interventions as President on Oct. 6 and will become CEO on Jan. 1. Former COE Kimble Jenkins, who has led the company since 2003, will assume the position of executive chairman on Jan. 1 and will continue to be actively involved with the company.
MRI Interventions makes platforms for minimally invasive surgical procedures in the brain and heart.